(NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare ...

Experts discuss PPI use for GI protection in patients on antithrombotics, highlighting risk factors, dosing, drug ...

MediWound (MDWD) stock rises 4% as it begins Phase 3 trials for EscharEx treating venous leg ulcers, with FDA submission plans and mid-2026 interim ...

A "TRAUMATISED" teen was told he was coughing up "pints" of blood due to a stomach ulcer after eating too many kebabs - but ... harmful to the body's cardiovascular systems as cigarettes". 4. It could ...

[35] The addition of a second procedure reduced the rate of recurrent bleeding from 18.4% to 10.6% ... therapy is the treatment of choice for high-risk bleeding peptic ulcers.

Theralase® validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the ...

One-year follow-up data demonstrates sustained improvements across venous specific quality-of-life (QoL) indicators.

The clinical and financial implications of inpatient dermatology were examined, highlighting the need for systemic changes to ...

This Press Release updates numerical list in reference section Theralase® validates previous University of Manitoba research ...

Stem cell therapy is emerging as a potential treatment for different conditions in endocrinology, including diabetes and ...

A systematic review and meta-analysis of five studies suggested that patients on GLP-1 receptor agonists were more likely to ...